121 related articles for article (PubMed ID: 26148290)
1. Anakinra Improves Pyoderma Gangrenosum in Psoriatic Arthritis: A Case Report.
Acquitter M; Plantin P; Kupfer I; Auvinet H; Marhadour T
Ann Intern Med; 2015 Jul; 163(1):70-1. PubMed ID: 26148290
[No Abstract] [Full Text] [Related]
2. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum in a patient with psoriatic arthritis.
Spangler JG
J Am Board Fam Pract; 2001; 14(6):466-9. PubMed ID: 11757891
[No Abstract] [Full Text] [Related]
4. Anakinra for recalcitrant pyoderma gangrenosum.
O'Connor C; Gallagher C; Hollywood A; Paul L; O'Connell M
Clin Exp Dermatol; 2021 Dec; 46(8):1558-1560. PubMed ID: 34137070
[TBL] [Abstract][Full Text] [Related]
5. Pyoderma gangrenosum in association with psoriatic arthritis.
Smith DL; White CR
Arthritis Rheum; 1994 Aug; 37(8):1258-60. PubMed ID: 8053964
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pyoderma gangrenosum associated with IgA gammopathy with the IL-1 receptor antagonist anakinra.
Rousset P; Dugourd PM; Lanteri A; Montaudié H; Passeron T
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e447-e450. PubMed ID: 33657262
[No Abstract] [Full Text] [Related]
7. Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene.
Lin Z; Hegarty JP; Lin T; Ostrov B; Wang Y; Yu W; Kelly AA; Poritz LS; Koltun WA
Inflamm Bowel Dis; 2011 Jun; 17(6):E41-2. PubMed ID: 21438098
[No Abstract] [Full Text] [Related]
8. Successful treatment of pyoderma gangrenosum with anakinra in a patient with Wiskott-Aldrich syndrome.
Mercuri SR; Paolino G; De Flammineis E; Didona D; Brianti P
Dermatol Ther; 2018 Mar; 31(2):e12582. PubMed ID: 29214738
[No Abstract] [Full Text] [Related]
9. Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients.
Beynon C; Chin MF; Hunasehally P; Bhagwandas K; Bevan M; Taylor M; Lawson T
J Clin Rheumatol; 2017 Apr; 23(3):181-183. PubMed ID: 28333874
[No Abstract] [Full Text] [Related]
10. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature.
Zonana-Nacach A; Jiménez-Balderas FJ; Martínez-Osuna P; Mintz G
J Rheumatol; 1994 Jul; 21(7):1352-6. PubMed ID: 7966084
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical uveitis and pyoderma gangrenosum in a patient with psoriatic arthritis under infliximab treatment.
Fujimoto N; Yamasaki Y; Watanabe R
J Dtsch Dermatol Ges; 2018 Sep; 16(9):1139-1140. PubMed ID: 30129996
[No Abstract] [Full Text] [Related]
12. Variable expression and treatment of PAPA syndrome.
Schellevis MA; Stoffels M; Hoppenreijs EP; Bodar E; Simon A; van der Meer JW
Ann Rheum Dis; 2011 Jun; 70(6):1168-70. PubMed ID: 21325428
[No Abstract] [Full Text] [Related]
13. Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment.
Caorsi R; Picco P; Buoncompagni A; Martini A; Gattorno M
J Rheumatol; 2014 Nov; 41(11):2333-4. PubMed ID: 25362725
[No Abstract] [Full Text] [Related]
14. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M
Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847
[No Abstract] [Full Text] [Related]
15. Anakinra for flares of pyogenic arthritis in PAPA syndrome.
Dierselhuis MP; Frenkel J; Wulffraat NM; Boelens JJ
Rheumatology (Oxford); 2005 Mar; 44(3):406-8. PubMed ID: 15637033
[No Abstract] [Full Text] [Related]
16. [Anakinra therapy in a patient with multifocal pyoderma gangrenosum and hidradenitis suppurativa].
Oymanns M; Kreuter A; Assaf C
Hautarzt; 2021 May; 72(5):435-438. PubMed ID: 33095334
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.
Benzaquen M; Monnier J; Beaussault Y; Rouby F; Berbis P
Australas J Dermatol; 2017 Nov; 58(4):e270-e271. PubMed ID: 28660635
[No Abstract] [Full Text] [Related]
18. Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
Lee WS; Choi YJ; Yoo WH
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e75-e77. PubMed ID: 27325564
[No Abstract] [Full Text] [Related]
19. [Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report].
Delbrel X; Germain P; Fach J; Etienne G; Beylot C; Parrens M; De Mascarel A; Le Bras M; Longy-Boursier M
Ann Med Interne (Paris); 2001 Feb; 152(1):65-7. PubMed ID: 11240430
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
Sakamoto T; Hashimoto T; Furukawa F
Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
